153 related articles for article (PubMed ID: 36418025)
1. Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.
Liu Q; Hu G; Ye B; Wang S; Wu Y
Pharm Stat; 2023 Mar; 22(2):349-364. PubMed ID: 36418025
[TBL] [Abstract][Full Text] [Related]
2. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD
Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
Dong G; Shih WJ; Moore D; Quan H; Marcella S
Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
[TBL] [Abstract][Full Text] [Related]
4. A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment ordering.
Serra A; Mozgunov P; Jaki T
Stat Med; 2023 Jul; 42(16):2841-2854. PubMed ID: 37158302
[TBL] [Abstract][Full Text] [Related]
5. Accounting for uncertainty in the historical response rate of the standard treatment in single-arm two-stage designs based on Bayesian power functions.
Matano F; Sambucini V
Pharm Stat; 2016 Nov; 15(6):517-530. PubMed ID: 27766770
[TBL] [Abstract][Full Text] [Related]
6. Bayesian Sample Size Planning Tool for Phase I Dose-Finding Trials.
Lin X; Lyu J; Yuan S; Bi D; Wang SJ; Ji Y
JCO Precis Oncol; 2022 Aug; 6():e2200046. PubMed ID: 36001859
[TBL] [Abstract][Full Text] [Related]
7. Adaptive blinded sample size adjustment for comparing two normal means--a mostly Bayesian approach.
Hartley AM
Pharm Stat; 2012; 11(3):230-40. PubMed ID: 22422722
[TBL] [Abstract][Full Text] [Related]
8. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.
Calderazzo S; Wiesenfarth M; Kopp-Schneider A
Biostatistics; 2022 Jan; 23(1):328-344. PubMed ID: 32735010
[TBL] [Abstract][Full Text] [Related]
9. Adaptive trial designs.
Lai TL; Lavori PW; Shih MC
Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
[TBL] [Abstract][Full Text] [Related]
10. Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD
Stat Methods Med Res; 2019 Jun; 28(6):1852-1878. PubMed ID: 29869564
[TBL] [Abstract][Full Text] [Related]
11. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD; Peduzzi PN
Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
[TBL] [Abstract][Full Text] [Related]
12. Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power.
Yang J; Li G; Yang D; Wu J; Wang J; Gao X; Liu P
BMC Med Res Methodol; 2024 Jan; 24(1):12. PubMed ID: 38233758
[TBL] [Abstract][Full Text] [Related]
13. Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter.
Waleed M; He J; Phadnis MA
J Biopharm Stat; 2024 Jul; 34(4):469-487. PubMed ID: 37545144
[TBL] [Abstract][Full Text] [Related]
14. Multi-stage dose expansion cohort (MSDEC) design with Bayesian stopping rule.
Wang S; Tan M
J Biopharm Stat; 2022 Jul; 32(4):600-612. PubMed ID: 35699319
[TBL] [Abstract][Full Text] [Related]
15. Bayesian sample size re-estimation using power priors.
Brakenhoff TB; Roes K; Nikolakopoulos S
Stat Methods Med Res; 2019 Jun; 28(6):1664-1675. PubMed ID: 29717945
[TBL] [Abstract][Full Text] [Related]
16. Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD; Makuch RW; Peduzzi PN
Contemp Clin Trials; 2015 Mar; 41():160-71. PubMed ID: 25583273
[TBL] [Abstract][Full Text] [Related]
17. Optimal adaptive promising zone designs.
Mehta C; Bhingare A; Liu L; Senchaudhuri P
Stat Med; 2022 May; 41(11):1950-1970. PubMed ID: 35165917
[TBL] [Abstract][Full Text] [Related]
18. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
Wang Y; Travis J; Gajewski B
BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
[TBL] [Abstract][Full Text] [Related]
19. Bayesian sample size calculations for comparing two strategies in SMART studies.
Turchetta A; Moodie EEM; Stephens DA; Lambert SD
Biometrics; 2023 Sep; 79(3):2489-2502. PubMed ID: 36511434
[TBL] [Abstract][Full Text] [Related]
20. An extension of Bayesian predictive sample size selection designs for monitoring efficacy and safety.
Teramukai S; Daimon T; Zohar S
Stat Med; 2015 Sep; 34(22):3029-39. PubMed ID: 26038148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
